Tag: Anil Matai
Budget 2025: OPPI hails initiatives for inclusive & innovation-driven healthcare landscape
Anil Matai, Director General, OPPI expresses commitment towards working alongside policymakers to further strengthen the sector and address areas that require continued attention
Budget 2025: OPPI seeks special incentives
Policy-level clarifications, such as expanded exemptions for life-saving drugs and oncology medications from import duty are vital for reducing treatment costs
OPPI welcomes Indian govt’s move to waive off local clinical trials...
This will be applicable to a few select drugs already approved in well-regulated markets like the USA, UK, Japan, Australia, Canada, and the EU
Budget 2024 reflects a forward-looking and inclusive approach: Anil Matai, DG,...
Anil Matai, Director General, Organisation of Pharmaceutical Producers of India (OPPI) appreciated the positive strides yet also emphasized that the government could have announced incentives for pharma companies to develop medications for rare diseases
OPPI appoints Anil Matai as Director-General
Anil Matai, a seasoned general management professional, has extensive experience in the Life Sciences space having worked across MNCs